|
27.02.2023 04:36:44
|
Pfizer In Talks To Buy Seagen : Report
(RTTNews) - Pfizer Inc. (PFE) is in talks to buy Seagen Inc. (SGEN) in a deal likely valued at more than $30 billion, the Wall Street Journal reported citing people familiar with the matter.
The potential deal would help the drug company add to its lineup of cancer treatments.
The talks are at an early stage and there is no guarantee there will be a deal, the Journal reported.
Seagen was in advanced talks last year to be acquired by Merck (MRK) in a deal that would have been worth $40 billion or more, the Wall Street Journal reported at the time, but the companies failed to reach agreement.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Pfizer Inc.mehr Nachrichten
Analysen zu Pfizer Inc.mehr Analysen
| 14.11.24 | Pfizer Neutral | UBS AG | |
| 01.11.24 | Pfizer Neutral | UBS AG | |
| 30.10.24 | Pfizer Buy | Goldman Sachs Group Inc. | |
| 29.10.24 | Pfizer Buy | Jefferies & Company Inc. | |
| 24.10.24 | Pfizer Neutral | JP Morgan Chase & Co. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.